{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:37:09Z","timestamp":1790786229400,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.omtm.2023.02.015","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T07:47:41Z","timestamp":1677743261000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungs"],"prefix":"10.1016","volume":"29","author":[{"given":"Yinghua","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Fakhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Huntemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Y.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Excoffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Limberis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kolbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2389-9277","authenticated-orcid":false,"given":"John F.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2023.02.015_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2023.02.015_bib2","doi-asserted-by":"crossref","first-page":"eS8","DOI":"10.1016\/S0929-693X(20)30044-0","article-title":"CFTR gene variants, epidemiology and molecular pathology","volume":"27","author":"Bareil","year":"2020","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.omtm.2023.02.015_bib3","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1038\/s41598-019-42404-6","article-title":"Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in\u00a0silico tools","volume":"9","author":"Pereira","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2023.02.015_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1089\/hum.2020.013","article-title":"Viral vectors, animal models, and cellular targets for gene therapy of cystic fibrosis lung disease","volume":"31","author":"Tang","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/genes9110538","article-title":"Cystic fibrosis gene therapy: looking back, looking forward","volume":"9","author":"Cooney","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.omtm.2023.02.015_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ymthe.2021.01.010","article-title":"Gene therapy for cystic fibrosis: lessons learned and paths forward","volume":"29","author":"Choi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/hgtb.2015.150","article-title":"Development of rAAV2-CFTR: history of the first rAAV vector product to be used in humans","volume":"27","author":"Loring","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2023.02.015_bib8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1089\/hum.1996.7.9-1145","article-title":"A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease","volume":"7","author":"Flotte","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib9","first-page":"748","article-title":"Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line","volume":"3","author":"Kearns","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib10","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1128\/JVI.00649-08","article-title":"Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle","volume":"82","author":"Penaud-Budloo","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.02.015_bib11","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","article-title":"Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue","volume":"72","author":"Duan","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.02.015_bib12","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1172\/JCI8317","article-title":"Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus","volume":"105","author":"Duan","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2023.02.015_bib13","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/jvi.76.5.2043-2053.2002","article-title":"Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors","volume":"76","author":"Yan","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.02.015_bib14","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.0813365106","article-title":"Directed evolution of adeno-associated virus to an infectious respiratory virus","volume":"106","author":"Excoffon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.02.015_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.omtm.2020.09.008","article-title":"Repeat dosing of AAV2.5T to ferret lungs elicits an antibody response that diminishes transduction in an age-dependent manner","volume":"19","author":"Tang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.02.015_bib16","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1073\/pnas.0409845102","article-title":"A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia","volume":"102","author":"Ostedgaard","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.02.015_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/hum.2015.001","article-title":"Optimization of recombinant adeno-associated virus-mediated expression for large transgenes, using a synthetic promoter and tandem array enhancers","volume":"26","author":"Yan","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib18","doi-asserted-by":"crossref","first-page":"L231","DOI":"10.1152\/ajplung.90209.2008","article-title":"Ciliated epithelial cell lifespan in the mouse trachea and lung","volume":"295","author":"Rawlins","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.omtm.2023.02.015_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1165\/ajrcmb.12.6.7766425","article-title":"Cell proliferation in bronchial epithelium and submucosal glands of cystic fibrosis patients","volume":"12","author":"Leigh","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omtm.2023.02.015_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","article-title":"Human immune responses to adeno-associated virus (AAV) vectors","volume":"11","author":"Ronzitti","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2023.02.015_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2023.02.015_bib22","doi-asserted-by":"crossref","first-page":"658399","DOI":"10.3389\/fimmu.2021.658399","article-title":"Anti-AAV antibodies in AAV gene therapy: current challenges and possible solutions","volume":"12","author":"Weber","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2023.02.015_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/hum.2011.147","article-title":"A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs","volume":"23","author":"Shin","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib24","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.mt.6300161","article-title":"Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression","volume":"15","author":"Wang","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/hum.2021.083","article-title":"Dexamethasone transiently enhances transgene expression in the liver when administered at late-phase post long-term adeno-associated virus transduction","volume":"33","author":"Chai","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib26","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B gene therapy with a high-specific-activity factor IX variant","volume":"377","author":"George","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.02.015_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamaophthalmol.2018.6902","article-title":"Immune response and intraocular inflammation in patients with leber hereditary optic neuropathy treated with intravitreal injection of recombinant adeno-associated virus 2 carrying the ND4 gene: a secondary analysis of a phase 1\/2 clinical trial","volume":"137","author":"Bouquet","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.omtm.2023.02.015_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-6143.2012.04337.x","article-title":"Ferret lung transplant: an orthotopic model of obliterative bronchiolitis","volume":"13","author":"Sui","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.omtm.2023.02.015_bib29","first-page":"5","article-title":"Individualizing immunosuppression in lung transplantation","volume":"2018","author":"McDermott","year":"2018","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.omtm.2023.02.015_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s40472-018-0199-4","article-title":"Immunosuppression for lung transplantation: current and future","volume":"5","author":"Chandrashekaran","year":"2018","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.omtm.2023.02.015_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtm.2019.12.008","article-title":"Immune response mechanisms against AAV vectors in animal models","volume":"17","author":"Martino","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.02.015_bib32","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3389\/fimmu.2018.02987","article-title":"Regulation of effector and memory CD8 T\u00a0cell differentiation by IL-2-A balancing act","volume":"9","author":"Kalia","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2023.02.015_bib33","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.4049\/jimmunol.168.11.5566","article-title":"Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T\u00a0cell responses","volume":"168","author":"D'Souza","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2023.02.015_bib34","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.4110\/in.2018.18.e33","article-title":"Direct antiviral mechanisms of interferon-gamma","volume":"18","author":"Kang","year":"2018","journal-title":"Immune Netw."},{"key":"10.1016\/j.omtm.2023.02.015_bib35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fimmu.2018.00888","article-title":"Tuning the cytokine responses: an update on interleukin (IL)-4 and IL-13 receptor complexes","volume":"9","author":"Junttila","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2023.02.015_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","article-title":"The two faces of IL-6 on Th1\/Th2 differentiation","volume":"39","author":"Diehl","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omtm.2023.02.015_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtm.2023.02.015_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar3150","article-title":"Type I IFN and TNFalpha cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance","volume":"12","author":"Cantaert","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib39","doi-asserted-by":"crossref","first-page":"e143004","DOI":"10.1172\/jci.insight.143004","article-title":"Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease","volume":"7","author":"He","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2023.02.015_bib40","doi-asserted-by":"crossref","first-page":"eaau7531","DOI":"10.1126\/scitranslmed.aau7531","article-title":"In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis","volume":"11","author":"Sun","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2023.02.015_bib41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1165\/rcmb.2013-0261OC","article-title":"Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets","volume":"50","author":"Sun","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omtm.2023.02.015_bib43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2023.02.015_bib45","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.02.015_bib46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/rccm.200410-1398OC","article-title":"Basal-like cells constitute the proliferating cell population in cystic fibrosis airways","volume":"172","author":"Voynow","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtm.2023.02.015_bib47","doi-asserted-by":"crossref","first-page":"9468","DOI":"10.1128\/JVI.73.11.9468-9477.1999","article-title":"Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination","volume":"73","author":"Yang","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.02.015_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.omtm.2022.01.007","article-title":"Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression","volume":"24","author":"Wang","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.02.015_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.omtm.2017.01.003","article-title":"Effective depletion of pre-existing anti-AAV antibodies requires broad immune targeting","volume":"4","author":"Velazquez","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.02.015_bib50","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3389\/fimmu.2019.01744","article-title":"Glucocorticoids-all-rounders tackling the versatile players of the immune system","volume":"10","author":"Strehl","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2023.02.015_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.omtm.2023.02.015_bib52","first-page":"69","article-title":"Azathioprine and the neurologist","volume":"20","author":"McWilliam","year":"2020","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.omtm.2023.02.015_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/hum.2016.113","article-title":"Induction of T-cell infiltration and programmed death ligand 2 expression by adeno-associated virus in rhesus macaque skeletal muscle and modulation by prednisone","volume":"28","author":"Cramer","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib54","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201708-1616OC","article-title":"Infection is not required for mucoinflammatory lung disease in CFTR-knockout ferrets","volume":"197","author":"Rosen","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtm.2023.02.015_bib55","first-page":"CD000407","article-title":"Oral steroids for long-term use in cystic fibrosis","volume":"2015","author":"Cheng","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.omtm.2023.02.015_bib56","author":"Waters"},{"key":"10.1016\/j.omtm.2023.02.015_bib57","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2021.287","article-title":"Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A","volume":"33","author":"Klamroth","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.015_bib58","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.omtm.2019.05.014","article-title":"Prevalence of anti-adeno-associated virus immune responses in international cohorts of healthy donors","volume":"14","author":"Kruzik","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.02.015_bib59","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3389\/fimmu.2017.01649","article-title":"Single dose of consensus hemagglutinin-based virus-like particles vaccine protects chickens against divergent H5 subtype influenza viruses","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:37:33Z","timestamp":1715953053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050123000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":57,"alternative-id":["S2329050123000256"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2023.02.015","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungs","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2023.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}